Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Emerging global value fund ventures into Iraq

Wednesday, February 12, 2014

amb
Kevin Martelli
Benedicte Gravrand, Opalesque Geneva for New Managers:

Last year, Kevin Martelli founded Martek Partners, which is the Switzerland, Lausanne-based investment advisory company for a value investment fund called A4 Investments - Martek Partners, which invests globally in public equities and other securities using a long term value approach.

The €10m fund was launched in April 2013 in a relatively challenging environment, because assets are very highly priced and it was difficult to find assets that provided the right margin of safety, Martelli said during the latest Opalesque Geneva Roundtable. For that reason, it has remained more than 70% in cash, so the performance in 2013 was 0%.

The fund manager follows a long-term value approach, and invests in any type of assets, including equities, bonds and derivatives, with absolutely no geographical restrictions.

"We invest globally, that means we consider literally all countries, including emerging as well as frontier markets," Martelli explains. "For example, personally I think one of the best opportunities available today is the Iraqi market, which happens to be one of the cheapest and highest growth markets with very low levels of debt, unlike developed countries. It is not easy to access this market, ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its